推薦產品
品質等級
化驗
≥95.0%
95%
形狀
crystals
mp
284-288 °C (lit.)
SMILES 字串
OB(O)c1ccc(Br)cc1
InChI
1S/C6H6BBrO2/c8-6-3-1-5(2-4-6)7(9)10/h1-4,9-10H
InChI 密鑰
QBLFZIBJXUQVRF-UHFFFAOYSA-N
尋找類似的產品？ 前往 產品比較指南
應用
试剂用于
试剂用于制备
- 钯催化 Suzuki-Miyaura 交叉偶联
- 钯(II)催化的非对映选择性共轭加成
- 钯催化烯丙基酯与芳基硼酸的立体选择性 Heck 型反应
- 串联型Pd(II)催化的氧化Heck反应和分子内C-H酰胺化序列
- 铜介导芳基硼酸与氟烷基碘的无连接有氧氟烷基化反应
- Pd催化炔烃的碳钯化芳基环化炔烃或烯酮
- 铜催化的交叉耦合
试剂用于制备
- 具有潜在抗肿瘤活性的含没食子酸酯的 obovatol 类似物
- 蛋白调节剂、酶抑制剂和激酶抑制剂
其他說明
含不定量的酸酐
訊號詞
Warning
危險聲明
危險分類
Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
標靶器官
Respiratory system
儲存類別代碼
11 - Combustible Solids
水污染物質分類（WGK）
WGK 3
個人防護裝備
dust mask type N95 (US), Eyeshields, Gloves
客戶也查看了
James A Jordan-Hore et al.
Organic letters, 14(10), 2508-2511 (2012-05-02)
Ligand-free cationic Pd(II) catalyst with NaNO3 as an additive is a highly active catalytic system for conjugate additions to sterically hindered γ-substituted cyclohexenones. More challenging γγ- and βγ-substrates also react well to produce products with quaternary centers in good dr.
Synthesis of obovatol derivatives and their preliminary evaluation as antitumor agents
Lee, M.-S.; et al.
Bull. Korean Chem. Soc., 28, 1601-1604 (2007)
Tahlia R Meola et al.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 129, 145-153 (2018-06-02)
The synergistic effect of nanosizing and lipid-based drug delivery systems (LBDDS) was explored to enhance formulation drug loading levels and improve drug solubilisation in the gastrointestinal environment. A novel formulation combining drug nanocrystals and silica-lipid hybrid (SLH) microparticles as a
Chuan Xiao et al.
Bioorganic & medicinal chemistry, 19(23), 7100-7110 (2011-11-01)
A series of purine nucleoside analogues bearing an aryl and hetaryl group in position 6 were prepared and their biological activities were assessed by in vitro CDK1/Cyclin B1 and CDK2/Cyclin A2 kinase assay. From the synthesized chemicals, three Xylocydine derivatives
Erin Tay et al.
Pharmaceutics, 12(1) (2019-12-28)
Lipid based formulations (LBFs) are commonly employed to enhance the absorption of highly lipophilic, poorly water-soluble drugs. However, the utility of LBFs can be limited by low drug solubility in the formulation. Isolation of ionizable drugs as low melting, lipophilic
Global Trade Item Number
| 庫存單位 | GTIN |
|---|---|
| B75956-5G | 4061833441992 |
我們的科學家團隊在所有研究領域都有豐富的經驗，包括生命科學、材料科學、化學合成、色譜、分析等.
聯絡技術服務